ITGAM and neoplasm: The results reported here demonstrate the ability of tumor-associated CD11b+ myeloid cells to convert genetically primed human (BPH-1) and murine (TRAMP C3) prostate epithelial cells from a non-tumorigenic to tumorigenic state.